Healthcare Infrastructure, Operations & Supply ChainTEVIMBRA Approved for First-Line ESCC Treatment with ChemoBusiness WireMarch 5, 2025March 18, 2025 by Business WireMarch 5, 2025March 18, 20250112 New indication based on results from a global Phase 3 trial demonstrating significantly improved overall survival benefit for PD-L1 positive patients treated with TEVIMBRA in...
